Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 308,304 | 308,718 | 214,841 | 216,515 | 280,499 |
| Receivables | 120,479 | 60,470 | 112,860 | 81,082 | 60,191 |
| Inventories | 60,887 | 80,070 | 84,708 | 82,134 | 65,674 |
| Income taxes - deferred | N/A | 1,483 | 1,483 | 1,656 | 1,710 |
| Other current assets | 29,282 | 0 | 0 | 0 | 0 |
| TOTAL | $537,410 | $473,490 | $435,488 | $405,811 | $432,175 |
| Non-Current Assets | |||||
| PPE Net | 327,808 | 327,643 | 320,084 | 315,489 | 313,979 |
| Intangibles | 81,759 | 112,323 | 114,695 | 98,186 | 110,929 |
| Other Non-Current Assets | 90,507 | 63,092 | 73,056 | 98,359 | 81,608 |
| TOTAL | $500,074 | $503,058 | $507,835 | $512,034 | $506,516 |
| Total Assets | $1,037,484 | $976,548 | $943,323 | $917,845 | $938,691 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 37,970 | 41,248 | 41,824 | 40,583 | 40,930 |
| Accrued Expenses | 38,205 | 34,303 | 32,762 | 25,424 | 37,928 |
| Other current liabilities | 2,109 | 4,440 | 5,033 | 9,024 | 8,733 |
| TOTAL | $99,611 | $88,725 | $86,962 | $80,297 | $92,936 |
| Non-Current Liabilities | |||||
| Long Term Debt | 246,892 | 253,000 | 253,000 | 251,000 | 251,000 |
| Deferred Revenues | 3,979 | 8,734 | 7,343 | 5,266 | 5,345 |
| Other Non-Current Liabilities | 27,538 | 23,524 | 35,027 | 42,864 | 35,841 |
| TOTAL | $277,856 | $282,511 | $294,110 | $299,670 | $292,554 |
| Total Liabilities | $377,467 | $371,236 | $381,072 | $379,967 | $385,490 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,474 | 38,943 | 38,800 | 38,357 | 37,918 |
| Common Shares | 40 | 39 | 39 | 38 | 38 |
| Retained earnings | 351,139 | 317,792 | 280,850 | 266,749 | 288,269 |
| Other shareholders' equity | -3,133 | -4,472 | -3,977 | -3,562 | -3,328 |
| TOTAL | $660,017 | $605,312 | $562,251 | $537,878 | $553,201 |
| Total Liabilities And Equity | $1,037,484 | $976,548 | $943,323 | $917,845 | $938,691 |